FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Flurox Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Prolonged use of a topical ocular anesthetic is not recommended. It may produce permanent corneal
opacification with accompanying visual loss. Avoid contamination - do not touch tip of sterile dropper
used to dispense solution to any surface. Replace container closure immediately after using.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
For procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent such as
tonometry, gonioscopy, removal of corneal foreign bodies and other short corneal or conjunctival procedures.
History
There is currently no drug history available for this drug.
Other Information
Flourescein Sodium and Benoxinate Hydrochloride Opthalmic Solution USP, 0.25%/0.4% is a disclosing agent with rapid anesthetic action of short duration.
Fluorescein Sodium is represented by the following structural formula:
Chemical Name: Spiro [isobenzofuran-1 (3H),9'-[9H] xanthene]-3-one, 3',6' dihydroxy, disodium salt.
Benoxinate Hydrochloride is represented by the following structural formula:
Chemical Name: 2-(Diethylamino) ethyl 4-amino-3butoxybenzoate monohydrochloride.
Sources
Flurox Manufacturers
-
Ocusoft, Inc.
Login To Your Free Account